The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Current therapeutics for Alzheimer’s disease and clinical trials”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
William G. Ryan, Hunter M. Eby, Nicole R. Bearss, Ali S. Imami, Abdul-rizaq Hamoud, Priyanka Pulvender, Justin L. Bollinger, Eric S. Wohleb, Robert E. McCullumsmith. 2025; https://doi.org/10.1101/2025.04.18.649617 |
|
2 |
2025 |
Saif Ahmad Khan, Zufika Qamar, Aashish Rohilla, Pirthi Pal Singh, Suhel Parvez, Sanjula Baboota, Javed Ali. Prospective Utilization of Nanocarriers Loaded with Drug Combination for Treating Alzheimer's Disease, Current Pharmaceutical Design. 2025; 31: 1444. https://doi.org/10.2174/0113816128348877241202053633 |
|
3 |
2025 |
Ryszard Pluta, Editorial: Alzheimer’s disease, Exploration of Neuroscience. 2025; 4: 100694. https://doi.org/10.37349/en.2025.100694 |
|
4 |
2025 |
Pornthip Waiwut, Pitchayakarn Takomthong, Rutchayaporn Anorach, Nattareeyada Lomaboot, Supawadee Daodee, Yaowared Chulikhit, Orawan Monthakantirat, Charinya Khamphukdee, Chantana Boonyarat. Pharmacological Evaluation of a Traditional Thai Polyherbal Formula for Alzheimer’s Disease: Evidence from In Vitro and In Silico Studies, International Journal of Molecular Sciences. 2025; 26: 6287. https://doi.org/10.3390/ijms26136287 |
|
5 |
2025 |
Dar Junaid Bashir, Khursheed Ahmad Bhat, Masarat Bashir. Deciphering Alzheimer’s disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier, Brain Research. 2025; 1863: 149828149828. https://doi.org/10.1016/j.brainres.2025.149828 |
|
6 |
2025 |
Pallavi Gangarde, Shvetank Bhatt, Rohini Pujari. Assessment of neuroprotective potential of Cuscuta reflexa in aluminium chloride-induced experimental model of Alzheimer’s disease: In vitro and in vivo studies, Journal of Trace Elements in Medicine and Biology. 2025; 88: 127612127612. https://doi.org/10.1016/j.jtemb.2025.127612 |
|
7 |
2026 |
Asma Sardar, Rafaqat Hussain, Shoaib Khan, Tayyiaba Iqbal, Hina Sarfraz, Ayaz Ali Khan, Ammena Y. Binsaleh, Nawal Al-Hoshani, Maher S. Alwethaynani, Nuha Anajirih, Fakhria A. Al-Joufi. In Vitro Biological Screening and In Silico Molecular Modeling Studies of Thiadiazole-Bearing Benzoxazole Derivatives as Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors, Journal of Computational Biophysics and Chemistry. 2026; 25: 1497. https://doi.org/10.1142/S2737416525501042 |
|
8 |
2025 |
Andrey V. Kuznetsov, 2025; https://doi.org/10.1101/2025.02.28.640920 |
|
9 |
2024 |
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, Dania Thaher, Weam Jaghama, Donia Karaman, Rafik Karaman. Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease, Molecules. 2024; 29: 5131. https://doi.org/10.3390/molecules29215131 |
|
10 |
2025 |
Zufika Qamar, Saif Ahmad Khan, Pallavi Kumari, Mariya Khan, Pushadapu Veera Venkata Siva Krishna, Shweta Dang, Sanjula Baboota, Asgar Ali, Javed Ali. Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- Current progress and future perspectives part I: Receptor-mediated nose-to-brain delivery approaches for glioblastoma, Expert Opinion on Drug Delivery. 2025; 17425247.2025.2578384. https://doi.org/10.1080/17425247.2025.2578384 |
|
11 |
2025 |
Betül Kaya, Ulviye Acar Çevik, Bilge Çiftçi, Adem Necip, Mesut IŞIK, Ebru Nur Ay, Süleyman Yur, Yusuf Özkay, Şükrü Beydemir, Zafer Asım Kaplancıklı. Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer’s Disease, ACS Omega. 2025; 10: 38427. https://doi.org/10.1021/acsomega.5c01055 |